NanoValent Pipeline



The following publications provide the latest documentation for the various technologies and projects referenced above:

1. Salvador-Morales, C, Zhang, L, Langer, R, Farokhzad, OC (2009) Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials 30: 2231–2240.

2. Kang, H, Nagy, J Triche, T: Targeted therapy of leukemia and Ewing’s sarcoma by human antibody-targeted nanoparticles. AACR Mini-Symposium :New Molecular Advances in Pediatric Cancer”, AACR Annual Meeting, 2016.